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ABSTRACT
A retrospective study was conducted of 26 adult
cases of fusobacterium bacteraemia that occurred
between 1998 and 2003 at Center Hospitalier
Universitaire de Grenoble, France. Most patients
presented with pre-existing adverse medical con-
ditions, including evolving malignant diseases
(eight patients), recent surgery (four patients),
and chronic organ failure (six patients). Only one
patient presented with a classic Lemierre’s syn-
drome. These results suggest an opportunistic
pattern of modern fusobacterium infections.
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Fusobacterium spp. are the second most frequent
Gram-negative anaerobic bacteria isolated from
human blood after Bacteroides spp. Fusobacterium-
associated diseases originate from the normal
ﬂora of the oral cavity, digestive tract or genital
tract. Fusobacterium necrophorum and Fusobacterium
nucleatum are the predominant species implicated
in cases of human bacteraemia. Both species are
well-known aetiological agents of Lemierre’s syn-
drome, but Fusobacterium spp. are also important
pathogens in immunocompromised patients, e.g.,
those receiving myelotoxic chemotherapy [1–3] or
those who have undergone gastrointestinal sur-
gery [4].
The present study included all adult patients
between 1998 and 2003 in the Center Hospitalier
Universitaire de Grenoble, France (2100 adult
beds), who had at least one blood culture positive
for Fusobacterium spp. Blood samples were ana-
lysed with the BACTEC 9240 system (Becton
Dickinson, Pont de Claix, France), with identiﬁ-
cation by API 20 A and API 32 A (bioMe´rieux,
Marcy l’Etoile, France). Medical conditions and
clinical symptoms were recorded. Pre-existing
chronic organ dysfunction was recorded if previ-
ous repeated creatinine clearance values were
< 60 mL ⁄min, or there was known cirrhosis,
cardiac dysfunction or previous chronic oxygen
therapy. Haemostasis disorder was deﬁned by at
least two of the following: an international
normalised ratio > 1.4 (in the absence of anti-
vitamin K medication); an activated partial
thromboplastin time > 40 s (in the absence of
heparin administration); and a platelet blood
count < 200 000 ⁄mm3.
In total, 6274 bacteraemias were recorded,
including 26 (0.4%) episodes caused by Fusobac-
terium spp. The mean age of patients with fuso-
bacterium bacteraemia was 56.4 years (range
18–91 years). Most (n = 20; 76.9%) were male
(Table 1). Eight (30.8%) patients presented with
an underlying active malignant disease. Four
(15.4%) had received myelotoxic chemotherapy
during the preceding month. Four (15.4%) of the
patients with a neoplasm were neutropenic at the
time of bacteraemia (three because of chemother-
apy and one because of the neoplasm itself). Four
(15.4%) patients had undergone surgery within
the preceding 2 weeks, and two more had under-
gone surgery within the preceding 3 months.
Eleven (42.3%) patients had a central venous
catheter (CVC) (six with a vascular access port
and ﬁve with short-term CVCs). Fifteen (57.7%)
patients had no previous diagnosis of cancer, no
recent surgery, and no CVC. One presented
with a gut perforation secondary to toothpick
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Table 1. Patient and infection characteristics for 26 cases of fusobacterium bacteraemia
Age
(years) Gender
Underlying adverse
condition(s) Central
venous
catheter
Primary
infectious site
Secondary
infectious site Thrombophlebitis
Haemostasis data
Species
Organisms
in blood culture
Outcome of
fusobacterium
infection
(days before death)Type Details APTT INR PBC
75 F Cancer Leukopenia
secondary
to ChT
for
lymphoma
Yes ND
Digital necrosis
Yes 58 1.4 114 nucl – Favourable
49 M Colic
adenocarcinoma
with
intestinal
occlusion
Yes Lung abscess 44 1.8 355 nucl – Favourable
68 F Relapsing
acute
myeloid
leukaemia;
leukopenia
Yes Pneumonia nucl – Death (14)
65 F Acute
myeloid
leukaemia
after
bone
marrow
transplantation
for
Waldenstrom’s
disease
Yes Pneumonia 33 2.5 41 nucl – Death (1)
48 M Pharynx
carcinoma;
tracheostomy
Yes Mediastinitis
Pneumonia
Yes nucl Staphylococcus
epidermidis
Favourable
52 M Leukopenia
and
mucositis
secondary
to ChT
and bone
marrow
transplantation;
diabetes
Yes ND 43 1.2 110 nucl Staphylococcus
constellatus
Favourable
64 M Cancer
and
surgery
ChT for
relapsing
post-kidney
transplantation
lymphoma;
laparotomy
for tumoral
biopsy
Yes ND 37 1.3 218 nucl – Favourable (18)
27 M Splenectomy;
leukopenia
secondary to
ChT for acute
lymphoblastic
leukaemia
Yes Cholecystitis 41 1.8 29 necr Staphylococcus aureus,
Enterococcus faecalis
Favourable (57)
72 M Surgery Surgery
for small bowel
adhesiolysis
No ND nucl – Favourable
45 M Recent coronary
bypass
Yes ND 45 1.6 115 necr Staphylococcus
anginosus
Favourable
49 M Chronic
organ
dysfunction
Cirrhosis;
diabetic
acidocetosis
No Pneumonia 71 4.7 42 nucl – Favourable
68 M Paraplegia;
renal
dysfunction
No Decubitus ulcer nucl Streptococcus F,
Peptostreptococcus spp.
Favourable
72 M Respiratory and
renal
dysfunction
No Pneumonia nucl – Favourable
55 M Cirrhosis No ND 54 2 61 nucl – Favourable (91)
91 M Lung ﬁbrosis;
cardiac
dysfunction
No Diarrhoea and
liver abscess
nucl Peptostreptococcus
36 M Cardiac
dysfunction;
recent cardiac
arrest; small
bowel
dilatation
Yes ND necr – Favourable (41)
Research Notes 179
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 178–196
ingestion, while ﬁve (19.2%) presented with
pre-existing kidney, lung, heart or liver failure.
A primary infectious site was identiﬁed for 16
patients (Table 1). In the two cases of prostatitis,
the prostate was not considered to be the pri-
mary site of infection, as spontaneous anaerobe
infection of the prostate seems unlikely [5]. A
secondary site of infection was identiﬁed for four
cases (Table 1). A venous thrombosis was found
in three cases, all of which involved F. nucleatum;
two cases involved a catheterised sub-clavicular
vein, while the third presented with classic
Lemierre’s syndrome. Haemostasis data were
available for 17 patients (Table 1), 12 of whom
had a haemostasis disorder.
Patients presenting with F. necrophorum bacter-
aemia (n = 20; 76.9%) were younger than those
presenting with F. nucleatum bacteraemia (n = 6;
23.1%) (mean age 38.1 vs. 61.9 years; p 0.013).
Blood was the only sample positive for Fusobac-
terium. All fusobacterium isolates were suscept-
ible to ampicillin and none were b-lactamase
producers. Blood cultures yielded multiple micro-
organisms in nine (34.6%) cases (Table 1).
Eight (30.8%) patients died within 3 months of
fusobacterium bacteraemia, which was the pro-
bable cause of death in three (11.5%) cases (with a
fatal outcome at 1, 6 and 14 days, respectively,
after blood culture). In a fourth case, there was
clinical improvement for 12 days, followed by
fatal bilateral pneumonia within 6 days, but fuso-
bacterium bacteraemia was not considered to be
the primary cause of death. In the remaining four
patients, the time between fusobacterium isolation
from blood and death (41–91 days; Table 1) was
too long to consider fusobacterium bacteraemia as
being directly responsible for the fatal outcome.
Antibiotic regimens differed considerably. With
the exception of patients with tonsillitis, a broad-
spectrum antibiotic regimen was chosen because
of the severe clinical presentation, and antibiotic
combinations were administered before blood
culture results were available. All fusobacterium
isolates were susceptible to at least one of the
antibiotics administered. The antibiotic regimens
were not modiﬁed following receipt of blood
culture results.
Recent advances in medical care have drama-
tically increased the number of patients exposed
to a high risk of infection. In the present study,
four patients had undergone recent surgery
(including splenectomy in one case), while four
had received myelotoxic chemotherapy. Six
patients had a vascular access CVC, suggesting
seriously impaired health. Among the remaining
patients, ﬁve presented with a pre-existing organ
failure. Thus, fusobacterium bacteraemia oc-
curred predominantly (17 ⁄ 26 patients; 65.4%) in
patients with impaired health. Primary fuso-
bacterium infection of a catheter could be hypo-
thesised for the 11 patients with a CVC. However,
the skin is usually not colonised by Fusobacterium
spp. [6]. In four of these patients, multiple
microorganisms were isolated from blood, which
is infrequent in catheter-related bacteraemia. The
source of infection was probably the lung, the gut
or the pharynx for six of these 11 patients. In two
other patients presenting with leukopenia, the
Table 1. Continued
Age
(years) Gender
Underlying adverse
condition(s) Central
venous
catheter
Primary
infectious site
Secondary
infectious site Thrombophlebitis
Haemostasis data
Species
Organisms
in blood culture
Outcome of
fusobacterium
infection
(days before death)Type Details APTT INR PBC
70 F Other Diabetes No Pneumonia nucl – Favourable (81)
54 M Paraplegia No Decubitus ulcer 52 1.9 572 nucl – Favourable
58 F Gut perforation No Psoas abscess 34 1.1 282 nucl Prevotella oralis,
Escherichia coli K1
Favourable
57 M Subdural
haematoma
Yes ND 45 1.5 154 nucl – Favourable
28 M None None No Pharynx abscess
Lung abscess
(Lemierre’s syndrome)
Yes 34 1.1 35 nucl – Favourable
55 M None No Pneumonia 52 2.3 98 nucl Peptostreptococcus Death (6)
80 M None No ND (prostatitis) 45 1.5 196 nucl – Favourable
25 M None No Tonsillitis
Cutaneous abscess
34 1.2 191 necr – Favourable
18 F None No Pharynx abscess necr – Favourable
75 M None No ND (prostatitis) 26 1.2 151 necr Escherichia coli Favourable
ChT, chemotherapy; ND, not determined; nucl, Fusobacterium nucleatum; necr, Fusobacterium necrophorum; APTT, activated partial thromboplastin time (s); INR, international
rationalised ratio: PBC, platelet blood count (g ⁄L).
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probable source was bacterial translocation
through the intestinal wall. The two cases of
thrombophlebitis of a vein catheterised with a
deep catheter device were probably caused by a
secondary catheter infection.
Mortality associated with fusobacterium bac-
teraemia was 11.5%. Considering the poor under-
lying medical condition of most of the patients,
death may have been secondary to the severe
underlying disease rather than fusobacterium
infection. Fusobacterium spp. remain highly sus-
ceptible to ﬁrst-line antibiotics such as b-lactams
[7], but penicillinase production has been repor-
ted for some strains of F. nucleatum [8].
Only one patient presented with classic Lemi-
erre’s syndrome, perhaps because many cases of
undiagnosed fusobacterium tonsillitis are treated
with b-lactams before the onset of Lemierre’s
syndrome. In other countries, restricted use of
antibiotics for tonsillitis has been associated with
an increased risk of F. necrophorum sepsis [9].
Twelve patients presented with a haemostasis
disorder associated with both F. nucleatum and
F. necrophorum. This may reﬂect a non-speciﬁc
haemostasis disorder, although F. necrophorum
has been shown to display platelet-aggregating
activity [10]. This has not been demonstrated for
F. nucleatum. The present data indicate that both
Fusobacterium spp. have a direct and speciﬁc effect
on haemostasis.
Fusobacterium spp. should be considered as
opportunistic pathogens in patients with im-
paired health status, caused by recent surgery
(especially of the gut), evolving neoplasm,
myelotoxic chemotherapy and perhaps deep
venous catheterisation. Lemierre’s syndrome,
which was once a classic clinical presentation
of fusobacterium infections, may become infre-
quent in developed countries. Secondary hae-
mostasis disorders are frequently associated
with fusobacterium bacteraemia. Nevertheless,
the mortality rate of fusobacterium bacteraemia
remains low.
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Calcoﬂuor and Blankophor, for the
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ABSTRACT
Fluorescent whiteners, such as Blankophor and
Calcoﬂuor white, bind to chitin and cellulose, and
ﬂuoresce when exposed to UV light. Detection of
fungal elements from skin and nail samples was
faster and more accurate using Blankophor com-
paredwith potassium hydroxide preparations and
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